PMID: 4885615Mar 8, 1969Paper

Controlled trial of dipyridamole in cerebral vascular disease

British Medical Journal
J AchesonE C Hutchinson

Abstract

A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.

References

Sep 25, 1965·Lancet·P R EmmonsJ R Mitchell
Sep 11, 1967·JAMA : the Journal of the American Medical Association·S Sbar, R C Schlant
May 1, 1968·The American Journal of the Medical Sciences·J M SullivanR Gorlin
Sep 12, 1968·The New England Journal of Medicine·J M SullivanR Gorlin
Apr 1, 1967·Circulation Research·S Afonso, G S O'Brien
Sep 17, 1960·British Medical Journal·T FOULDS, J MACKINNON
Mar 1, 1963·American Heart Journal·A C DEGRAFF, A F LYON
Jun 1, 1964·Angiology·A LEIBERMAN, S GUGLIELMELLI
Aug 1, 1965·The American Journal of Cardiology·M T NEWHOUSE, M MCGREGOR

❮ Previous
Next ❯

Citations

Dec 17, 1993·Pharmacy World & Science : PWS·A Keyser
Mar 1, 1970·Atherosclerosis·G Danta
Jul 1, 1979·Progress in Cardiovascular Diseases·A I Schafer, R I Handin
Jan 1, 1986·General Pharmacology·M OhashiK Nishino
Dec 1, 1986·Journal of the American College of Cardiology·D G Sherman, R G Hart
Dec 10, 1970·The New England Journal of Medicine·H J Weiss
Jun 24, 1971·The New England Journal of Medicine·J M SullivanR Gorlin
Dec 4, 1975·The New England Journal of Medicine·E GentonL A Harker
Jan 26, 1995·The New England Journal of Medicine·H J BarnettH E Meldrum
Apr 23, 2003·Cardiology in Review·Jesse WeinbergerDawn Terashita
Oct 27, 1972·Annals of the New York Academy of Sciences·J F MustardM A Packham
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R S Marshall, J P Mohr
Sep 1, 1994·Journal of Endovascular Surgery : the Official Journal of the International Society for Endovascular Surgery·R T HigashidaG B Hieshima
Jul 30, 2003·Clinical Pharmacokinetics·Thomas Lenz, Amy Wilson
Jan 1, 1981·Journal of Neurosurgery·S Wessler, S N Gitel
Jan 1, 1983·Journal of Neurosurgery·N F KassellJ A Sprowell
May 13, 1998·British Journal of Clinical Pharmacology·C R Gibbs, G Y Lip
Sep 21, 2004·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Daniel G Hackam, Moira K Kapral
Jan 1, 1991·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·N Futrell, C H Millikan
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Hans-Christoph Diener
Aug 1, 1995·Journal of the Neurological Sciences·J M Bertrand-HardyI Welbers
Jan 1, 1983·Thrombosis Research. Supplement·T D Bjornsson, C Mahony
May 1, 1980·Progress in Cardiovascular Diseases·J D Easton, J A Byer
Aug 1, 1977·American Journal of Surgery·J M Porter, S H Goodnight
Dec 1, 1976·The American Journal of Medicine·M Verstraete
Jan 1, 1993·Nihon rinsho. Japanese journal of clinical medicine·T Koyama, E Kakishita
Aug 1, 1983·Current Problems in Cardiology·J D EastonM Kaste
Aug 1, 1975·The Journal of Surgical Research·J Swedenborg, S I Schwartz
Jul 1, 1990·Baillière's Clinical Haematology·W J Oczkowski, A G Turpie
Dec 1, 1978·American Heart Journal·S Wessler, S N Gitel
Aug 29, 2014·Cephalalgia : an International Journal of Headache·Anne P HansenNanna B Finnerup
Jun 1, 1982·Cephalalgia : an International Journal of Headache·W K Amery
Nov 1, 1982·Stroke; a Journal of Cerebral Circulation·D J BoariniJ A Sprowell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.